JAMP POMALIDOMIDE

Identification of Jamp Pomalidomide

No description

Google image searchProduct monograph

Active ingredient

pomalidomide, 4 MG

DIN: 02538091

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: JAMP PHARMA CORPORATION

Date: 01-AUG-2023

ATC:

Reference brand drug: Pomalyst

Search on Google